Publications by authors named "D Sommerhalder"

Claim this Profile
A
A phase Ib/II study of modakafusp alfa alone and in combination with pembrolizumab in patients with advanced or metastatic solid tumors.
David Gill, Charles L Cowey, Gregory A Daniels, David Sommerhalder, Raghad Abdul-Karim

Front Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of HH2853, a novel EZH1/2 dual inhibitor, in patients with refractory solid tumours or non-Hodgkin lymphomas: a phase I study.
Zhengfu Fan, Jin Wang, Dan Liu, Lin Shen, Meiyu Fang, David Sommerhalder

EClinicalMedicine· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 study of zavondemstat (TACH101), a first-in-class KDM4 inhibitor, in patients with advanced solid tumors.
Apostolia M Tsimberidou, Farshid Dayyani, David Sommerhalder, Andrae L Vandross, Meredith S Pelster

Oncologist· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A B7H3-targeting antibody-drug conjugate in advanced solid tumors: a phase 1/1b trial.
Yuxiang Ma, Yunpeng Yang, Yan Huang, Wenfeng Fang, Jinhui Xue, David Sommerhalder

Nat Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human phase I study to evaluate safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity, and antitumor activity of PF-07209960 in patients with advanced or metastatic solid tumors.
A Naing, M McKean, L S Rosen, D Sommerhalder, N M Shaik

ESMO Open· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis